CAS 1622075-65-3

Moxetumomab

CAS : 1622075-65-3

A recombinant CD22-targeting monoclonal antibody

Ref: 3D-CLA1632

Moxetumomab

CAS : 1622075-65-3

Moxetumomab is a monoclonal antibody targeting CD22, which can be used to synthesise ADC Moxetumomab pasudotox for the study of hairy cell leukaemia (HCL).

Degré de pureté : 97.4% (SDS-PAGE); 97.8% (SEC-HPLC) - ≥95% (SDS-PAGE); 96.64% (SEC-HPLC)

Couleur et forme : Liquid

Masse moléculaire : ~150 kDa

Ref: TM-T76693